Pharm-Olam’s Case Study on Automated Sample Retention for BA/BE

This case study reviews Pharm-Olam’s Automated Sample Retention Solution that was used in a recent study.

MARCH 12, 2015

Bioavailability and Bioequivalence (BA/BE) studies require samples of investigational product retained. Typically, this is performed manually and overseen by clinical monitors during site initiation. This manual approach is feasible for limited sites, but larger site numbers make manual retention less feasible. This case study reviews Pharm-Olam’s Automated Sample Retention Solution that was used in a recent study.

To read the complete case study click here.

Share this: